awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37360151-07FB4260-05B8-4CB0-9235-F9A734B5EC58
Q37360151-07FB4260-05B8-4CB0-9235-F9A734B5EC58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37360151-07FB4260-05B8-4CB0-9235-F9A734B5EC58
Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.
P2860
Q37360151-07FB4260-05B8-4CB0-9235-F9A734B5EC58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37360151-07FB4260-05B8-4CB0-9235-F9A734B5EC58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
05eff86165fed16de499d60381537ce66f50812a
P2860
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.